Recognized globally as experts in neurocognition and pharmacologic treatment of CNS disorders, the NeuroCog Trials Scientific Team has been instrumental in hundreds of research projects and clinical trials. Below are links to key articles that comprise a portion of our scientific library.

Validation of the tablet-administered Brief Assessment of Cognition (BAC App)


The validation study of our proprietary Brief Assessment of Cognition (BAC App) is now in press in Schizophrenia Research, available as Open Access PDF. To facilitate the administration of our widely-used pen-and-paper neurocognitive battery, the Brief Assessment of Cognition (BAC), we developed a regulatory compliant … Continued

Tagged: , , ,

NeuroCog Trials Receives $2 Million Grant from the National Institute of Mental Health – Press Release


NIH Grant Will Support the Collection of US Census-Matched Norms and Internationalization of the Virtual Reality Functional Capacity Assessment Tool, VRFCAT™.   DURHAM, NORTH CAROLINA, August 11, 2016 – NeuroCog Trials, Inc., the leading cognitive services provider for the clinical trials industry, today announced that … Continued

Tagged: , , , ,

Assessing the Impact of Centralized Data Review on the Reliability of the Alzheimer’s Disease Assessment Scale-Cognitive (ADAS-Cog)


The Alzheimer’s Disease Assessment Scale Cognitive Subscale (ADAS-Cog) is the primary neurocognitive outcome measure in many clinical trials for mild-moderate Alzheimer’s disease (AD). Despite wide use, variations in administration and scoring are well-documented, and may reduce reliability and sensitivity of the measure. Variations in administration … Continued

Tagged: , , , , , , , , , ,
Page 1 Page 2 Page 3 Page 22